GlassScriptPhysician profile
Harvey J Hashimoto
NPI 1578506952
$17,833.92
in general payments reported to CMS, 2019-2025
44 companies · $2,423 in 2025
The $2,423 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,858 · 2020: $402 · 2021: $881 · 2022: $4,075 · 2023: $3,561 · 2024: $4,634 · 2025: $2,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,736 · Travel and Lodging: $1,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,735.68 |
| Travel and Lodging | $1,881.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $6,937.80 | 2021-2024 | |
| Mimedx Group, INC. | $2,915.09 | 2024-2025 | |
| Smith+Nephew, INC. | $2,362.75 | 2019-2025 | Collagenase Santyl, Oasis, Grafix |
| Astrazeneca Pharmaceuticals LP | $633.25 | 2019-2024 | Airsupra, Breztri |
| Lilly USA, LLC | $628.57 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $606.53 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $576.86 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $482.84 | 2019-2020 | |
| Organogenesis INC. | $327.35 | 2019-2021 | |
| Urgo Medical North America, LLC | $306.53 | 2023-2025 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Molnlycke Health Care US, LLC | $221.71 | 2021-2025 | Exufiber, Mepitel One, Mepilex Border Flex |
| Silk Road Medical, INC. | $206.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.71 | 2019-2025 | Jardiance |
| Integra Lifesciences Corporation | $129.24 | 2019-2024 | Tcc-Ez |
| Medline Industries LP | $117.66 | 2021 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $113.02 | 2023-2025 | Shingrix, Arexvy |
| Melinta Therapeutics, LLC | $109.68 | 2019-2022 | |
| Kerecis Limited | $106.73 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbott Laboratories | $96.34 | 2025 | Freestyle Libre 3 |
| Tei Medical INC. | $89.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.00 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $62.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.09 | 2023-2025 | |
| Next Science LLC | $52.35 | 2022-2023 | Surgx, Xperience, Blastx |
| Merck Sharp & Dohme LLC | $42.20 | 2019 | |
| Pfizer INC. | $40.64 | 2019-2024 | |
| Kci USA, INC. | $39.59 | 2021-2022 | |
| Exact Sciences Corporation | $36.59 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $35.81 | 2019-2023 | Repatha, Otezla |
| Medtronic, INC. | $29.85 | 2024 | Venaseal |
| Convatec INC. | $22.87 | 2022 | |
| Boston Scientific Corporation | $21.65 | 2020 | |
| Resmed Corp | $21.63 | 2022 | |
| Tactile Systems Technology INC | $20.26 | 2025 | Nimbl, Flexitouch Plus |
| Sumitomo Pharma America, INC. | $20.15 | 2025 | Gemtesa |
| Osiris Therapeutics INC. | $18.48 | 2019 | |
| Bsn Medical INC | $18.10 | 2019 | |
| Medela LLC | $16.38 | 2020 | |
| Dynavax Technologies Corporation | $15.21 | 2023 | Heplisav-B |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.35 | 2019 | |
| Amniox Medical, INC. | $12.23 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.20 | 2019 | |
| Sanofi Pasteur INC. | $11.69 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Hashimoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.